Documents | Delirium: prevention, diagnosis and management | Guidance | NICE

Documents

A list of downloadable documents created during development.

Stakeholder list updated

Stakeholder list ^{PDF 119.3 KB} 31 October 2018

Surveillance consultation

Surveillance consultation
Surveillance review proposal ^{PDF 1.01 MB} 31 August 2018
Comments form ^{MSWord 28.42 KB} 31 August 2018

Review documents

Surveillance review proposal information
Stakeholder list - review proposal ^{PDF 191.39 KB} 30 October 2014
Review proposal ^{PDF 471.33 KB} 30 October 2014
Surveillance review decision ^{PDF 699.1 KB} 28 January 2015

Other information

Evidence update ^{PDF 350.42 KB} 01 April 2012

Background information

Remit

Remit ^{PDF 13.77 KB} 31 October 2007

Stakeholder list and how to register

List of stakeholders ^{PDF 23.32 KB} 12 July 2010

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Final scope ^{PDF 110.86 KB} 03 July 2008
Stakeholder comments on draft scope ^{PDF 199.04 KB} 12 August 2008
Scope consultation information
Draft scope for consultation ^{PDF 119.21 KB} 16 April 2008
Draft scope comments proforma ^{MSWord 47.5 KB} 16 April 2008
List of stakeholders ^{PDF 23.32 KB} 12 July 2010

Guideline development and consultation

Guideline development and consultation
Equalities impact assessment (recommendations) ^{PDF 28.87 KB} 28 July 2010
GDG membership list ^{PDF 18.8 KB} 03 July 2008
Minutes for GDG meetings
Delirium GDG minutes: 16 July 2009 ^{PDF 34.54 KB} 20 October 2009
Delirium GDG minutes: 15 July 2009 ^{PDF 34.93 KB} 20 October 2009
Delirium GDG minutes: 22 April 2009 ^{PDF 34.42 KB} 20 October 2009
Delirium GDG minutes: 3-4 July 2008 ^{PDF 38.08 KB} 22 October 2008
Delirium GDG minutes: 13 November 2008 ^{PDF 19.16 KB} 17 March 2009
Delirium GDG minutes: 21-22 January 2009 ^{PDF 20.42 KB} 22 April 2009
Delirium GDG minutes: 4 March 2009 ^{PDF 86.5 KB} 30 July 2009
Draft guideline consultation information
Draft full guideline for consultation ^{PDF 1.85 MB} 11 November 2009
Algorithm ^{PDF 44.66 KB} 11 November 2009
Appendices
Appendices and contents page ^{PDF 614.71 KB} 11 November 2009
Appendix D adverse effects - included studies ^{PDF 233.49 KB} 11 November 2009
Appendix D consequences of - included studies ^{PDF 154.95 KB} 11 November 2009
Appendix D diagnostic test accuracy - included studies ^{PDF 181.98 KB} 11 November 2009
Appendix D epidemiology - included studies ^{PDF 214.03 KB} 11 November 2009
Appendix D non pharmacological risk factors - included studies ^{PDF 90.21 KB} 11 November 2009
Appendix D pharmacological risk factors - included studies ^{PDF 49.01 KB} 11 November 2009
Appendix E consequences of cohort studies - methodological quality ^{PDF 124.54 KB} 11 November 2009
Appendix E diagnostic accuracy tests - methodological quality ^{PDF 171.77 KB} 11 November 2009
Appendix E epidemiology - methodological quality ^{PDF 167.77 KB} 11 November 2009
Appendix E non-pharmacological risk factors cohort studies - methodological quality ^{PDF 43.9 KB} 11 November 2009
Appendix E pharmacological risk factors cohort studies - methodological quality ^{PDF 29.05 KB} 11 November 2009
Appendix E patient information - methodological quality ^{PDF 213.11 KB} 11 November 2009
Appendix F consequences of - multivariate risk factors ^{PDF 185.25 KB} 11 November 2009
Appendix F - non-pharmacological risk factors - multivariate risk factors ^{PDF 292.98 KB} 11 November 2009
Appendix F pharmacological risk factors - multivariate risk factors ^{PDF 62.99 KB} 11 November 2009
Appendix G diagnostic test accuracy - excluded studies ^{PDF 128.07 KB} 11 November 2009
Appendix G adverse effects review - excluded studies ^{PDF 121.1 KB} 11 November 2009
Appendix G consequences of - excluded studies ^{PDF 54.59 KB} 11 November 2009
Appendix G epidemiology review - excluded studies ^{PDF 146.42 KB} 11 November 2009
Appendix G non-pharmacological risk factors - excluded studies ^{PDF 71.11 KB} 11 November 2009
Appendix G information for patients review - excluded studies ^{PDF 117.62 KB} 11 November 2009
Appendix G pharmacological risk factors - excluded studies ^{PDF 55.41 KB} 11 November 2009
Appendix G references to excluded studies ^{PDF 151.11 KB} 11 November 2009
Appendix K evidence summary - prevention ^{PDF 33.66 KB} 11 November 2009
Appendix K evidence summary - treatment ^{PDF 38.63 KB} 11 November 2009
Draft NICE guideline for consultation ^{PDF 250.25 KB} 11 November 2009
Consultation table and with developers responses ^{PDF 1.02 MB} 07 May 2010
List or registered stakeholders information
Published clinical guidelines information
clinical guidelines in development information
Clinical guidelines in development information

Pre-publication check

Pre-publication check information
Pre-publication check - stakeholder comments/developer responses ^{PDF 48.62 KB} 28 July 2010
Full guideline ^{PDF 3.5 MB} 07 May 2010
Full guideline appendices
Appendix A - Scope ^{PDF 64.28 KB} 07 May 2010
Appendix B - Declaration of Interests ^{PDF 48.97 KB} 07 May 2010
Appendix C - Search Strategies ^{PDF 174.24 KB} 07 May 2010
Appendix D - Adverse Effects - Included studies ^{PDF 121.1 KB} 07 May 2010
Appendix D - Consequences of - Included studies ^{PDF 154.95 KB} 07 May 2010
Appendix D - Diagnostic Test Accuracy - Included Studies ^{PDF 181.98 KB} 07 May 2010
Appendix D - Epidemiology - Included studies ^{PDF 91.05 KB} 07 May 2010
Appendix D - Non pharmacological Risk factor - Included studies ^{PDF 43.9 KB} 07 May 2010
Appendix D - Pharma Nonpharma Prevention Treatment - Included studies ^{PDF 170.26 KB} 07 May 2010
Appendix D - Pharmacological Risk factors - Included studies ^{PDF 49.01 KB} 07 May 2010
Appendix E - Consequences of ^{PDF 124.54 KB} 07 May 2010
Appendix E - Diagnostic Accuracy Tests Methodological Quality ^{PDF 171.77 KB} 07 May 2010
Appendix E - Epidemiology quality ^{PDF 71.45 KB} 07 May 2010
Appendix E - Non Pharmacological Risk Factors ^{PDF 43.9 KB} 07 May 2010
Appendix E - Patient info quality ^{PDF 79.7 KB} 07 May 2010
Appendix E - Pharma NonPharma Prevention Treatment ^{PDF 106.61 KB} 07 May 2010
Appendix E - Pharmacological Risk Factors review - Randomised controlled trials ^{PDF 22.51 KB} 07 May 2010
Appendix E - Pharmacological Risk Factors review - cohort studies ^{PDF 29.94 KB} 07 May 2010
Appendix G - References for Excluded Studies ^{PDF 93.24 KB} 07 May 2010
Appendix H - Recommendations for Future Research ^{PDF 75.27 KB} 07 May 2010
Appendix I - DSM-IV and Scales For Measuring ^{PDF 64.14 KB} 07 May 2010
Appendix J - Health Economics ^{PDF 155.25 KB} 07 May 2010
Appendix K - Forest Plots ^{PDF 462.32 KB} 07 May 2010
Full guideline appendices
Consultation table and with developers responses ^{PDF 1.02 MB} 07 May 2010

National Clinical Guideline Centre for Acute and Chronic Conditions

National Clinical Guideline Centre for Acute and Chronic Conditions information